US President Trump announced to impose 100% tariff on Pharma Products
By
Dr. Somita
Chakraborty
In his own social
media platform, US President Donald Trump declared that he is going to impose
100% tariff on branded or patented pharmaceutical products from 1st
October, 2025. The announcement exempts generic drugs – though, it is still not
clear that how Trump administration is going to interpret the term ‘branded’.
President Trump also asks manufacturers to build plants in the US to receive
relief. He also indicated to impose tariffs on kitchen cabinets, bathroom
vanities and associate products.
How it is
going to affect India
In the immediate
nature, the tariff is not going to affect India. India exports generic medicine
to America, consisting 40% of US total generic medicine import. For India, it a
USD $20 billion business. A number of internationally reputed Indian
pharmaceutical companies like Dr. Reddy’s Laboratories, Sun Pharma, Aurobindo
Pharma etc. exports generic drugs to the US. Trump’s 100% tariff, which is
going to increase prices of branded and patented medicine in US market, will
increase demand of generic low-cost medicine. This could increase India’s
pharma export to the US.
For detail
Donald Trump’sdrug tariff spares generics, but India braces for fallout
Comments
Post a Comment